KARA Institute for Neurological Diseases

Sydney, New South Wales 2113

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer Disease

Studies at this site

• A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease — Completed
• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) — Running, not enrolling